Orchid Counters Roche Claims In Boniva Patent Suit

Law360, New York (December 16, 2008, 12:00 AM EST) -- Orchid Chemicals & Pharmaceuticals Ltd. and its Orgenus Pharma Inc. subsidiary have fired back at Hoffmann-La Roche Inc. in an infringement suit over a patent for Roche's blockbuster osteoporosis drug Boniva Once-Monthly, seeking declaratory judgment of invalidity and noninfringement.

Orchid lodged the counterclaims Monday in the U.S. District Court for the District of New Jersey, where a separate lawsuit between the companies over two different patents related to Boniva is pending.

The patent-at-issue in the current suit is U.S. Patent Number 7,410,957. In its counterclaims, India-based...
To view the full article, register now.